Objective To analyze the efficacy of Kangfuyan Capsule combined with laparoscopy in the treatment of pelvic adhesions with chronic pelvic pain. Methods The clinical data of 86 patients with pelvic adhesions and chronic pelvic pain admitted to our hospital from September 2018 to May 2020 were analyzed. According to the treatment method, they were divided into traditional Chinese and western medicine groups (Kangfuyan capsule combined with laparoscopy treatment, n=46) and Control group ( laparoscopy treatment, n=40). The clinical efficacy and safety between the two groups were compared, and the improvement of pain, quality of life and inflammatory factors before and after treatment were compared. Results There was no statistically significant difference between the two groups of pre-treatment digital pain scoring (NPRS) (P＞0.05). After treatment, the NPRS scores of the two groups decreased significantly, and reached the lowest value after treatment for 3 months. At the same time, the NPRS scores of the Chinese and Western medicine group were low at all time points after treatment than those in control group (P＜0.05). The total clinical effective rate (97.83%) of the Chinese and Western medicine group was significantly higher than that of the control group (82.50%) (P＜0.05). Before treatment, there was no difference in the scores of physical function, psychological function, social function and mental function between the two groups (P＞0.05). After treatment, the scores of physical function, mental function, social function and mental function of the traditional Chinese and Western medicine group were higher than those before treatment and the control group (P＜0.05). Before treatment, there was no significant difference in serum amyloid A (SAA), immunoturbidimetric method for C-reactive protein (CRP) and procalcitonin (PCT) levels between the two groups (P＞0.05). After treatment, the levels of SAA CRP and PCT in the Chinese and Western medicine group were lower than those in the same group before treatment and the control group (P＜0.05). There was no difference in the incidence of complications and adverse reactions between the two groups (P＞0.05). Conclusion Kangfuyan capsule combined with laparoscopy can improve the pain of patients with pelvic adhesions and chronic pelvic pain, relieve inflammation response,and improve the efficacy of surgery and the quality of life of patients. It is safe and worthy of clinical promotion.